Drugs / QI-019A Injection
last change Mar 2026 re-read 3 minutes ago

QI-019A Injection

Developed for
plasma cell myeloma
Investigated by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Trials 1

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07429721 Mar 2026 → Jun 2028 expected plasma cell myeloma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as QI-019A Injection ClinicalTrials.gov intervention name — accepted as the source's own label NCT07429721 ↗